Biodexa Pharmaceuticals Plc (MTP)
Chart Events
Performance Outlook
| Previous Close | 0.3498 |
| Open | 0.3500 |
| Bid | 0.0000 x 1200 |
| Ask | 0.0000 x 3000 |
| Day's Range | 0.2851 - 0.3500 |
| 52 Week Range | 0.2851 - 21.0000 |
| Volume | |
| Avg. Volume | 977,632 |
| Market Cap | 1.236M |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.5700 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Biodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
Biodexa Pharmaceuticals PLC (AIM:BDRX)(NASDAQ:BDRX), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it has today issued to various investors 6,218,265 new ordinary shares of £0.02 each in the Company ("New Ordinary Shares"), pursuant to exercise notices in respect of 1,243,653 B Warrants received yesterday.
- ACCESSWIRE
Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease
Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines, is pleased to announce a new research programme coded MTD217 focusing on developing new therapeutic options for metastatic cancers with high unmet needs.
- ACCESSWIRE
Midatech Pharma PLC Announces Results of General Meeting
Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce that at the general meeting of the Company held earlier today (the "General Meeting"), all resolutions put to the Company's shareholders ("Shareholders") were duly passed.
